Mirum Pharmaceuticals (MIRM) earnings, Aug 5, 2026: EPS −783%, stock −11.0%
In brief
Mirum Pharmaceuticals reported on Aug 5, 2026. Earnings per share changed −783% year over year, 42.8% below the estimate; revenue +38%. The stock opened with a −14.7% gap and closed the day −11.0% (Aug 6, 2026). The stock is now 28.0% below its 52-week high, +33.5% over 12 months. Next report: Mar 10, 2027.
EPS vs estimate−42.8%
EPS, YoY−783%
Revenue, YoY+38%
Gap · day−14.7% · −11.0%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Aug 5, 2026 | −14.7% | −11.0% |
Next-quarter estimates, ratings and the MIRM chart are in the terminal.
Open the terminalFAQ
When is Mirum Pharmaceuticals's next earnings report?
Mar 10, 2027. The date comes from daily data and is corrected if the company moves it.
How did Mirum Pharmaceuticals stock react to the report?
Opening gap −14.7%, day's result −11.0%.
Did Mirum Pharmaceuticals's earnings grow?
Earnings per share fell 783% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.